Vanderbilt University Medical Center (VUMC) has been designated a Comprehensive Radiopharmaceutical Therapy Center of Excellence by the Society of Nuclear Medicine and Molecular Imaging. It is the only such center in Tennessee.
The designation affirms that VUMC has been found to have the training, personnel, equipment, and experience needed to manage patients requiring radiopharmaceutical therapy.
“We are grateful for the experience, expertise, and enthusiasm shared by team members in helping our nuclear medicine therapy service to thrive and grow,” said Philip Scherer, MD, associate professor of Radiology, section chief of Nuclear Medicine, and director of Nuclear Medicine and Positron Emission Tomography (PET) at VUMC.
“Receiving this designation is a collaborative team effort with nuclear medicine physicians, technologists, radiation safety officers, medical physicists, radiochemists, radiopharmacists, and oncology physicians,” Scherer said.
“Congratulations to the entire team on this distinction,” said Dan Brown, MD, professor of Radiology and Biomedical Engineering, and interim chair of the Department of Radiology. “This designation shows the dedication of our faculty and staff in providing the best care possible for our patients.”
With 15,000 members worldwide, the society promotes the science, technology, and practical applications of nuclear medicine and molecular imaging. To date, more than 30 comprehensive radiopharmaceutical centers of excellence have been designated in the United States and Canada.
